PELNSEPiramal Enterprises Limited· PharmaceuticalsMediumNeutral
Announced Wed, 4 Jun · 20:19 IST

Piramal Enterprises Limited has informed the Exchange about Investor Presentation

Mgmt Guided Margin ImprovementAnalyst Day Multiyear TargetsInvestor Communications View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Enterprises shared its investor presentation ahead of an IndiaBonds webinar on June 5, 2025. FY25 consolidated AUM grew 17% YoY to INR 80,689 Cr, with the retail-to-wholesale mix improving to 80:20 from 70:30. Growth business now accounts for 91% of total AUM, and the company returned to profitability with a consolidated PAT of INR 485 Cr versus a loss of INR 1,684 Cr in FY24. For FY26, management guided for ~25% YoY AUM growth (~INR 100k Cr), 2.5-3x profit growth (PAT of INR 1,300-1,500 Cr), and retail share rising to 80-85%. The proposed merger of PEL with PFL is expected to complete by Q2 FY26, simplifying the group structure.

Likely market impact

Positive for shareholders: the presentation signals a clear turnaround with stabilized profitability, a sharply reduced legacy book, strong capital adequacy (23.6%), and ambitious FY26 growth targets. The pending PEL-PFL merger should create a single branded pure-play NBFC, which may improve valuation clarity and trading liquidity for the stock.